Natural history of cerebral cavernous malformations by Kestle, John R. W. & Kondziolka, Douglas
AVERNOUS malformations (cavernous angiomas
and angiographically occult vascular malforma-
tions) are congenital vascular anomalies of the
brain. Their recognition as incidental or symptomatic vas-
cular malformations has been facilitated by magnetic res-
onance (MR) imaging.8 Along with arteriovenous mal-
formations (AVMs), cavernous malformations constitute
vascular malformations that are often symptomatic and
require management by neurosurgeons or neurologists.
They can be located in any brain region, be of varying
size, and present with different clinical disorders. His-
topathologically, they are characterized by dilated thin-
walled vascular channels lined by a simple endothelium
and thin fibrous adventitia; typically, no brain parenchyma
is found within the lesion.
Management strategies for cavernous malformations
remain complex. This report defines the natural history of
these lesions to improve our base of knowledge upon
which future management decisions are made. Robinson,
et al.,10 calculated the annual bleed rate in 57 patients as
0.7%, and Curling, et al.,1 found an annual rate of 0.25%
in their group of 32 patients. Zabramski, et al.,13 calculat-
ed an incidence of symptomatic hemorrhage of 1.1% per
lesion per year in 31 patients with familial cavernous mal-
formations. These hemorrhage rates are generally lower
than those reported for AVMs.6
After the development of our stereotactic radiosurgery
program in 1987, we evaluated an increasing number of
patients with cavernous malformations. We entered all pa-
tients selected for conservative management into a reg-
istry designed to assess the prospective natural history of
the disorder. Our goal was to obtain valuable information
regarding the outcome of cavernous malformations and
their collective rates of symptomatic hemorrhage, seizure
development, and subsequent need for treatment. We
planned to correlate preregistry clinical criteria with the
observed prospective outcome.
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U To determine the natural history of brain cavernous malformations, the authors entered patients referred to their center
into a prospective registry between 1987 and 1993. All patients underwent magnetic resonance imaging, which showed
the typical appearance of this lesion, and conservative management was recommended in all. Patients or their referring
physicians were contacted for follow-up data. The purpose of the study was to define the rate of symptomatic hemorrhage
and to determine the outcome in those patients who had suffered seizures. 
Follow-up data were available for 122 patients with a mean age at entry of 37 years (range 4–82 years). The malfor-
mation was located in the brainstem in 43 cases (35%), the basal ganglia/thalamus in 20 (17%), and a hemispheric area in
59 (48%). Fifty percent of patients had never had a symptomatic hemorrhage, 41% had one bleed, 7% had two, and 2%
had three. Seizures were reported in 23% of patients and headaches in 15%. Lesions were solitary in 80% of patients and
multiple in 20%. The retrospective annual hemorrhage rate (61 bleeds/4550.6 patient-years of life) was 1.3%.
The mean prospective follow-up period was 34 months. There were nine bleeds during this time, six with new neuro-
logical deficits. In patients without a prior bleed, the prospective annual rate of hemorrhage was 0.6%. In contrast, patients
with prior hemorrhage had an annual bleed rate of 4.5% (p = 0.028). Patient sex (p = 0.97) or the presence of seizures
(p = 0.11), headaches (p = 0.06), or solitary versus multiple lesions (p = 0.15) were not significant predictors of later hem-
orrhage. There was no difference in the rate of bleeds between brain locations. Four patients with seizures became seizure-
free and four patients without seizures later developed seizures; only one patient developed intractable seizures. Fourteen
patients (11%) underwent surgery (two after hemorrhage, five with seizures, and seven with progressive deficits), and five
had radiosurgery. No patient died in the follow-up period. This study indicates that conservative versus operative man-
agement strategies may need to be redefined, especially in patients who present with hemorrhage and who appear to have
a significantly increased risk of subsequent rehemorrhage.  
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Clinical Material and Methods
From 1987 through 1993, the records and imaging stud-
ies of 235 patients with cavernous malformations were
reviewed at our multidisciplinary vascular malformation
conference at the University of Pittsburgh, attended by
neurosurgeons, neuroradiologists, and radiation oncolo-
gists. Conservative management was recommended for
162 patients, all of whom were entered immediately into
a prospective natural history registry. We recommended
conservative treatment if: 1) the patient had an asymp-
tomatic lesion; 2) the malformation was associated with a
medically controlled seizure disorder; 3) the malformation
was located in a critical brain region but the patient had
only one hemorrhage or minimal symptoms; 4) the patient
was elderly or medically infirm; or 5) the patient had mul-
tiple cavernous malformations and the actual symptomatic
lesion could not be determined. In the registry we record-
ed patient age, sex, number of prior hemorrhages, the
presence or absence of seizures or headache, brain loca-
tion, type of diagnostic imaging performed, date, and the
name and address of the referring physician.
The diagnosis of cavernous malformation was based on
high-resolution MR imaging, supplemented in many cases
by computerized tomography. All patients had the typi-
cal MR imaging appearance of a cavernous malformation
(mixed internal signal, surrounded by a margin of low sig-
nal thought to represent hemosiderin).7,8 In all patients
who had angiograms (73 cases), no vascular abnormality
was identified in the area of the lesion. All patients with
prior symptomatic hemorrhage had confirmation of gross
bleeding on imaging studies. Two patients had coexisting
venous angiomas (Fig. 1). No patient who underwent an-
giography had an associated AVM or aneurysm. 
In June 1994, follow-up questionnaires were mailed to
all referring physicians. Patients without recent follow-up
data were contacted by telephone. We obtained informa-
tion on 122 patients (75%); 40 patients were lost to fol-
low-up review and could not be contacted by us or their
referring physicians. The following information was ob-
tained: development of new symptoms; dates of symp-
tomatic hemorrhage; development of seizures or control
of existing seizures; and whether microsurgery or radio-
surgery was performed (in which case patients were cen-
sored at the time of treatment). The results of imaging
studies performed at follow-up examinations were not
assessed by us. The occurrence of hemorrhage was docu-
mented on imaging studies evaluated by the referring
physicians. 
The series was divided into retrospective and prospec-
tive (after the date of entry into the registry) information
groups. Retrospectively, the hemorrhage rate per patient-
year of observation was calculated assuming that the le-
sion was present from birth to the time of entry into the
registry.1 Hemorrhage rates were compared using a chi-
square test. A logistic regression analysis was also per-
formed. Baseline factors collected at the time of entry into
the registry were used as independent variables (history of
prior hemorrhage, seizures, headache, gender, number of
lesions, and location). The dependent variable (outcome)
was the presence (or absence) of symptomatic hemor-
rhage in the follow-up period. A forward stepwise selec-
tion of variables was performed using the likelihood
ratio test. The data were analyzed by an independent




The study population of 122 patients consisted of 60
males and 62 females. Mean patient age was 37.3 years
(range 4–82 years). Sixty-one patients (50%) had never
sustained a clinically detectable hemorrhage. Fifty pa-
tients (41%) had one prior hemorrhage, nine (7%) had
two hemorrhages, and two (2%) had three hemorrhages.
Seizures were reported in 28 patients (23%) and
headaches in 18 (15%). Solitary cavernous malformations
were found in 97 patients (80%), whereas lesions were
multiple in 25 patients (20%). We did not count the num-
ber of cavernous malformations in each patient with mul-
tiple lesions to try to calculate a “rate per lesion”; rather,
we sought to determine the rate per patient in this multiple
subgroup. Because the number of detectable cavernous
malformations in some patients can increase over time
(especially in familial cases), imaging studies alone are
unlikely to determine the true number of malformations
present.3,13
Brainstem cavernous malformations were present in 43
patients (35%), 27 of whom had suffered a prior brainstem
hemorrhage. Twenty patients (17%) had malformations
in the basal ganglia or thalamus, and 59 patients (48%)
had a cerebral or cerebellar hemispheric malformation.
We combined cerebral and cerebellar hemisphere loca-
tions into one group because of their greater suitability for
surgical resection in comparison to brainstem or dien-
cephalic lesions. 
Retrospective Hemorrhage Rate
Prior to entry into the natural history registry, this co-
hort of 122 patients had sustained 61 hemorrhages in
4550.6 patient-years of life. This equaled a hemorrhage
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FIG. 1. Magnetic resonance images in a 38-year-old man with a
cavernous malformation medial to a venous malformation within
the left middle cerebellar peduncle. a: Long-TR image showing
the mixed-signal cavernous malformation and a flow-void area
within the transparenchymal draining vein (arrow) of the venous
malformation. b: Short-TR image with contrast enhancement
showing the radial collection of venous channels within the venous
malformation.
rate of 1.3% per year (under the assumption that the lesion
had been present since birth).
Prospective Risk of Hemorrhage and Seizures
During the mean prospective follow-up interval of 34
months (range 1–82 months), nine hemorrhages occurred.
Seven patients had one hemorrhage and one patient
had two hemorrhages. Thus, nine hemorrhages in 341.6
prospective years of observation equaled a 2.63% annual
hemorrhage rate in the overall patient group (Fig. 2). We
found no difference in the hemorrhage rate between men
and women (four in males, five in females, p = 0.97),
between patients with or without seizures (p = 0.11),
between patients with or without headaches (p = 0.06),
or between patients with solitary versus multiple lesions
(p = 0.15). In fact, no patient with multiple lesions had a
hemorrhage in the follow-up period. 
The most important risk factor for subsequent hemor-
rhage was the occurrence of a prior hemorrhage (Table 1).
Of the 61 patients who had never had a symptomatic hem-
orrhage, only one sustained a hemorrhage in the follow-up
period. This equaled a 0.6% annual hemorrhage rate in
this group. In the 61 patients who sustained a hemorrhage
before entry into the registry, eight hemorrhages in seven
patients were found in the follow-up period, for an an-
nual hemorrhage rate of 4.5% (p = 0.028). In the logistic
regression model, the most important determinant of
bleeding in the follow-up period was a history of prior
hemorrhage. Report of headaches was also a significant
predictor; however, the importance of such a report by the
patient remains unclear, because headache was not speci-
fied as to type. 
Brain location did not correlate with subsequent hemor-
rhage risk. Of the 43 patients with brainstem malforma-
tions, three sustained a hemorrhage in the follow-up peri-
od (prospective annual hemorrhage rate of 2.4%, Table 1).
Two of 20 patients with basal ganglia/thalamic malforma-
tions had a later hemorrhage (annual rate of 2.9%). Two of
59 patients with hemispheric malformations sustained one
hemorrhage and one suffered two hemorrhages (annual
rate of 2.7%). In this patient group, with a brainstem loca-
tion and a prior hemorrhage, we found a subsequent annu-
al hemorrhage rate of 5.0%.
Four (4.3%) of 94 patients without seizures developed
seizures in the follow-up period and four (14%) of 28
patients with seizures became seizure-free. Only one
patient developed intractable seizures. 
Surgical Management
Fourteen patients (11%) had microsurgery in the fol-
low-up interval. Two underwent resection of their malfor-
mation after sustaining a new hemorrhage, and five had
surgery for a persistent seizure disorder. Seven underwent
surgery because they suffered progressive neurological
deterioration, perhaps due to repeated microhemorrhage
within the cavernous malformation. No patient suffered
additional major morbidity after resection. Five addition-
al patients with recurrent hemorrhage had stereotactic ra-
diosurgery during the follow-up period, all for manage-
ment of recurrent hemorrhage. Four patients were treated
with the gamma knife,4 and one had proton beam irradia-
tion. No patient died in the follow-up period.
Discussion
The diversity of clinical presentations associated with
cerebral cavernous malformations is well reported.1,5,7,9–14
The widespread availability of MR imaging led to the sub-
sequent increased diagnosis of this vascular entity. Many
reports have emphasized the importance of surgical re-
section in the management of patients with hemorrhage,
poorly controlled seizures, or progressive neurological
deficits.5,10,14 Most authors conclude that the challenge of
cavernous malformation microsurgery is both finding the
lesion and minimizing trauma to adjacent brain tissue,
especially in areas of critical brain function. The actual
removal of the malformation usually proceeds uneventful-
ly. Before the value of surgical removal can be assessed,
the natural history of an unoperated cavernous malforma-
tion must be known. 
Value of MR Imaging for Diagnosis
All of the patients in the current series had MR images
that showed the typical appearance of a cavernous mal-
formation, agreed upon by neurosurgeons and neuroradi-
ologists at our vascular malformation conference. Because
neurosurgeons and neurologists will make management
decisions based on an imaging appearance and not the his-
tological appearance, we believe our reliance on imaging
appearance alone for entry into this study was appropriate. 
Many authors have stressed the differential diagnosis of
this imaging-defined lesion, which includes thrombosed
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FIG. 2. Kaplan–Meier curve showing the percentage of patients
without a symptomatic hemorrhage versus time (prospective as-
sessment).
TABLE 1
Annual hemorrhage rates for cavernous malformations
Prospective Annual 
Clinical Factors Hemorrhage Rate
no prior hemorrhage 0.6%
prior hemorrhage 4.5%
brainstem location 2.4%
basal ganglia/thalamus location 2.9%
hemisphere location 2.7%
brainstem location with prior hemorrhage 5.0%
or patent AVMs,2 venous malformations, mixed-type vas-
cular malformations, and tumors in addition to cavernous
malformations or angiomas.8 The hallmark is that they are
angiographically occult. However, the great majority of
lesions are pathologically confirmed to be cavernous mal-
formations, as identified on histological preparations after
surgery.5,12,14 Thus, we believe that the term “cavernous
malformation” is useful and appropriate for these lesions,
when high-quality MR imaging has been performed. Al-
though we initially performed conventional angiography
in all such patients to rule out an AVM or venous malfor-
mation, we have stopped using angiography when the MR
appearance is typical. 
Natural History
In 1991, Robinson, et al.,10 and Curling, et al.,1 present-
ed analyses of the natural history of cavernous malforma-
tions. In the series by Robinson, et al., over 14,000 con-
secutive MR images performed at the Cleveland Clinic
between 1984 and 1989 were reviewed. They identified
66 patients who had the typical MR appearance of a cav-
ernous malformation and followed these for a mean 26
months. Most patients presented with a seizure; 16% were
asymptomatic. Only one patient sustained a hemorrhage
during the follow-up period, for an annual bleeding rate of
0.7%. The small number of patients and the short follow-
up precluded an analysis of stratification variables for
hemorrhage risk. Their study suggested that male and fe-
male patients had a different hemorrhage risk, but this was
not confirmed in our study. The Cleveland Clinic report
emphasized the role of MR imaging in diagnosis and pro-
vided a natural history profile indicating a low risk for
overt hemorrhage. 
Curling, et al.,1 reported 32 patients who had 76 cav-
ernous malformations; these patients were discovered in a
review of 8131 MR images performed between 1986 and
1989. In their retrospective analysis, performed from the
time of birth up to the time of MR imaging diagnosis, they
calculated a symptomatic hemorrhage risk of 0.25% per
year. Surgical resection was performed and pathology
confirmed in seven of the 32 patients. They concluded
that, because the risk of significant hemorrhage from a
cavernous malformation was relatively low, hemorrhage
prevention should not be an absolute indication for surgi-
cal resection. They also acknowledged that the risk of re-
bleeding after an initial hemorrhage was unknown.1
Tung, et al.,12 reported 13 patients with recurrent hem-
orrhages from cavernous malformations located in all
brain regions. The median interval from first to second
hemorrhage was 12 months. They noted that all surgical
specimens showed histological evidence of chronic and
recent hemorrhage. In many patients multiple microscop-
ic hemorrhages occur, but are often not clinically detect-
ed.8,9,13 Only symptomatic hemorrhages were used to
guide management. They recommended surgical removal
for hemorrhagic malformations discovered in surgically
accessible, noncritical brain locations.12 Lesions found in
critical locations were removed only if recurrent hemor-
rhage had occurred. Simard, et al.,11 found a course of
repeated hemorrhages in patients with brainstem cav-
ernous malformations.
Zabramski, et al.,13 followed 31 patients with 128 fa-
milial cavernous malformations for a mean period of
2.2 years. The incidence of symptomatic hemorrhage was
1.1% per lesion per year. Six (29%) of 21 patients devel-
oped “new” lesions on serial MR images, at a rate of 0.4
new lesions per patient per year.13 The observation of in-
creasing numbers of malformations in family members
over multiple generations was also noted by Horowitz and
Kondziolka.3 Zabramski, et al., also reported the increased
risk of rehemorrhage after an initial hemorrhage.
Prior natural history studies have been based on an
analysis of consecutive MR images.1,10 In our series, pa-
tients were identified after referral to a tertiary care center
with microsurgical and radiosurgical expertise. Our series
may be affected by selection bias since our patients tend-
ed to have more complex clinical presentations or had pre-
sented difficulties in decision-making regarding therapeu-
tic options. This may have resulted in a higher number of
patients who had sustained prior hemorrhage in our study,
or a larger proportion of patients with lesions that were
symptomatic or in critical locations. However, because
of the number of patients in this study, we still had 61
patients who never bled who constituted a large group
with less complex presentations. In prospective analysis,
we stratified patients into different groups based on their
initial presentation. Our finding of a 0.6% annual hemor-
rhage rate in patients without prior hemorrhage is similar
to the risk identified by Robinson, et al.,10 (0.7%) but
slightly higher than that reported by Curling, et al.,1
(0.25%). This finding is important because it provides evi-
dence of the low risk for hemorrhage in patients with inci-
dental malformations and in those patients who present
with seizures only.
We and others12 suspect that patients who present with a
hemorrhage have an increased risk of subsequent hemor-
rhage. Our finding of an increased annual hemorrhage risk
of 4.5% in this group supports this hypothesis. This risk is
similar to that reported in the study of Ondra, et al.,6 in
regard to the natural history for hemorrhage in symptom-
atic AVMs. Six of the nine subsequent hemorrhages in
our series were associated with new neurological deficits,
although none led to death. Our experience suggests the
concept that rehemorrhage from a cavernous malfor-
mation may lead to increased deficits but rarely results in
patient mortality. 
Significant differences in the hemorrhage rates were not
found when patients were grouped according to history of
prior seizures, headaches, sex, lesion location, or number
of malformations. The occurrence of prior hemorrhage de-
fined a subgroup of patients with an increased risk of sub-
sequent hemorrhage. Perhaps surgical removal should be
considered for those patients who present with one hem-
orrhage, regardless of where the malformation is located.
The role of stereotactic radiosurgery in the management of
hemorrhagic, intraparenchymal, critically located malfor-
mations is currently being defined.4
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